Nociceptin receptor agonists

Drugs of the Future

Volumn 26, Issue 11, 2001, Pages 1059-1064

  Thomsen, C ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 2 [8 (NAPHTHALEN 1 YLMETHYL) 4 OXO 1 PHENYL 1,3,8 TRIAAZAPIRO[4.5]DEC 3 YL] ACETIC ACID METHYL ESTER; 3 [4 [2 [BIS(2 AMINOETHYL)AMINO]ETHYLAMINO]BUTYL] 8 (NAPHTHALEN 1 YLMETHYL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZA SPIRO[4.5]DECAN 4 ONE; 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; 8 (5,8 DICHLORO 1,2,3,4 TETRAHYDRONAPHTHALEN 2 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; 8 [BIS(2 METHYLPHENYL)METHYL] 3 PHENYL 9 AZABICYCLO[3.2.1]OCTAN 3 OL; CALCITONIN GENE RELATED PEPTIDE; ETORPHINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LOFENTANIL; NOCICEPTIN; NOCICEPTIN RECEPTOR AGONIST; SPIROXATRINE; UNCLASSIFIED DRUG; [8 (1 NAPHTHYLMETHYL) 4 OXO 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DEC 3 YL]ACETIC ACID METHYL ESTER;

ANOREXIA; ANXIETY; ASTHMA; COUGHING; DRUG ABUSE; DRUG SYNTHESIS; HUMAN; INCONTINENCE; INFLAMMATION; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; REVIEW; WASTING SYNDROME; WATER RETENTION;

EID: 0035685244     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.11.639494     Document Type: Review

References (54)

1. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
2. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
3. Orphanin FQ: A neuropeptide that activates an opioid like G protein-coupled receptor
4. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
5. Orphanin FQ/noci-ceptin - A role in pain and analgesia, but so much more
6. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1
7. High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor
8. 8-Acenaphthen-1-yl-1-phenyl1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists
9. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
10. Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opiods
11. Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay
12. Pharmacological profiles of fentanyl analogs at μ, κ and δ opiate receptors
13. Characterization of the cloned human μ-opioid receptor
14. 8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza- spiro[4.5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist
15. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation
16. Nociceptin/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions
17. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals
18. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice
19. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin
20. Bi-directional modulation of 5-hydroxytrypta-mine-induced plasma extravasation in the rat knee joint by nociceptin
21. Intradermal application of nociceptin increases vascular permeability in rats: The possible involvement of histamine release from mast cells
22. Recent advances in the understanding of the effects of opioid agents on feeding and appetite
23. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats
24. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo
25. Effect of nociceptin on alcohol intake in alcohol-preferring rats
26. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: Antagonism in brain and potentiation in spinal cord of the rat
27. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene
28. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence
29. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice
30. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
31. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
32. Influence of the selective ORL 1 receptor agonist, Ro64-6198, on rodent neurological function
33. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung
34. Nociceptin receptor activation inhibits tachykinergic nonadrenergic noncholinergic contraction of guinea pig isolated bronchus
35. Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors
36. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat
37. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat
38. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats
39. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep
40. Calcitonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potentials
41. Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats
42. Potent vasodilator activity of calcitonin gene-related peptide in human skin
43. Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide
44. Ca channel activation
45. The inhibitory effect of nociceptin on the micturition reflex in anaesthetized rats
46. Multiple sites of action in the inhibitory effect of nociceptin on the micturition reflex
47. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats
48. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)